BREAST CANCER STAGE IV
Clinical trials for BREAST CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER STAGE IV trials appear
Sign up with your email to follow new studies for BREAST CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diet and diabetes drug may boost breast cancer therapy
Disease control OngoingThis study tests if a very low-carb (ketogenic) diet, a low-carb diet, or the diabetes drug canagliflozin can prevent high blood sugar caused by the cancer drug alpelisib. The goal is to see if controlling blood sugar helps alpelisib work better for people with metastatic PIK3CA-…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Blood test finds hidden cancer; new drug aims to stop it
Disease control ENROLLING_BY_INVITATIONThis study is for people with a certain type of advanced breast cancer (HR+, HER2-low). First, a blood test looks for leftover cancer DNA after one month of standard hormone therapy and a CDK4/6 inhibitor. Those with positive results then receive trastuzumab deruxtecan, a targete…
Matched conditions: BREAST CANCER STAGE IV
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New study aims to close breast cancer care gaps for transgender individuals
Knowledge-focused OngoingThis study collects information from multiple hospitals about breast cancer in transgender and gender-diverse adults. Researchers will look at how the cancer was found, what risk factors were present, what treatments were used, and how well patients did over time. The goal is to …
Matched conditions: BREAST CANCER STAGE IV
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC
-
Exercise test may spot heart risks in breast cancer patients
Knowledge-focused OngoingThis study looks at whether a cardiopulmonary exercise test (CPET) can help predict heart and lung function in women with HER2-positive breast cancer who have mild heart problems from their treatment. About 23 women will do a special exercise test to measure oxygen use. The goal …
Matched conditions: BREAST CANCER STAGE IV
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:09 UTC